Our phase I units in the UK, India and Germany have Independent Ethics Committees constituted in accordance with ICH GCP.

In the UK Veeda CR’s Independent Ethics Committee is recognised by UKECA as a Type 1 REC for the review of phase I trials of medicinal products in healthy volunteers throughout the UK.

In Germany the IEC is part of the Medical Association of Saxony, constituted according to Saxonian law and operates according to ICH-GCP. It is additionally registered with the federal health authority for approval of studies of medical devices and studies using radiologic substances or methods.

The IEC functioning in Ahmedabad, India is constituted similarly to the UK committee and provides the same level of oversight of our Indian-based operations however classification of such committees is not current Indian practice.

The dates which Ethics Committees meet are as flexible as possible, usually once or twice a month. Submissions to the Ethics Committee are required 2 weeks prior to a meeting and the committees deliver as fast a response as possible, often the next day in the UK and India. Such a fast response depends both on the work of the committee and also the quality of the protocols submitted before the committee.

In Germany the approval period for a single centre trial is 30 days and the applicant is allowed to respond to scientific objections once within 90 days. However, through in-house review prior to submission, we try to recognise any problems prior to submission to the Ethics Committee and make necessary changes in advance to expedite the process.

Veeda Clinical Research is deeply grateful to the effort and commitment of all our Ethics Committees without whose co-operation and support we would be unable to function so effectively.